Natera Inc
NASDAQ:NTRA

Watchlist Manager
Natera Inc Logo
Natera Inc
NASDAQ:NTRA
Watchlist
Price: 139.95 USD -2.27%
Market Cap: 18.9B USD

P/E
Price to Earnings

-97.5
Current
-13
Median
21.5
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-97.5
=
Market Cap
18.6B USD
/
Net Income
-190.4m USD
Market Cap P/E
US
Natera Inc
NASDAQ:NTRA
18.6B USD -97.5
FR
Pharnext SCA
OTC:PNEXF
6T USD -173 083.5
US
Abbvie Inc
NYSE:ABBV
362.1B USD 85.4
US
Amgen Inc
NASDAQ:AMGN
165.8B USD 40.5
US
Gilead Sciences Inc
NASDAQ:GILD
140.8B USD 295.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
125.1B USD -232.4
US
Epizyme Inc
F:EPE
94.1B EUR -493.6
AU
CSL Ltd
ASX:CSL
124.8B AUD 28.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
67.4B USD 15.3
US
Seagen Inc
F:SGT
39.3B EUR -57.1
NL
argenx SE
XBRU:ARGX
31.9B EUR 41.7
Earnings Growth PEG
US
Natera Inc
NASDAQ:NTRA
Average P/E: 84.5
Negative Multiple: -97.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -173 083.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
85.4
87%
1
US
Amgen Inc
NASDAQ:AMGN
40.5
44%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
295.4
187%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -232.4 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -493.6 N/A N/A
AU
CSL Ltd
ASX:CSL
28.5
16%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.3
12%
1.3
US
S
Seagen Inc
F:SGT
Negative Multiple: -57.1 N/A N/A
NL
argenx SE
XBRU:ARGX
41.7
26%
1.6

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-61.9
2-Years Forward
P/E
-226.9
3-Years Forward
P/E
273.4